Ensera Launches Partnership Network With Medical Device Firms

Ensera, a global Contract Development and Manufacturing Organization (CDMO) for injectable drug programs, has launched the Ensera Alliance Network. This network aims to streamline the commercialization of drug-device combination products.

The initiative brings together leading specialists in medical device platforms and fill-finish services to address the complexities involved in bringing these products to market. Pharmaceutical companies often face challenges coordinating multiple specialized suppliers.

The network currently includes SHL Medical, Stevanato Group, and Ypsomed as providers of injection platforms, alongside Argonaut Manufacturing Services and American Injectables for fill-finish capabilities.

"Too many combination product programs are slowed down by non-communicating suppliers and complicated handoffs," stated Bobby O'Connor, Chief Commercial Officer at Ensera. He added that the network offers a more coordinated and responsive model to simplify commercialization and reduce risk for clients.

Ensera plans to expand the network over time, adding organizations that complement existing members' capabilities and meet evolving client needs. Participation in the network is non-exclusive, with members remaining independent entities.